Thermo Fisher Scientific Human IFN-beta Recombinant Protein, PeproTech
인간 유래 IFN-beta 재조합 단백질로, CHO 세포에서 발현된 고순도(≥95%) 제품입니다. 세포 독성 분석을 통해 활성이 검증되었으며, 바이러스 감염 및 면역 반응 연구에 적합합니다. 동결건조 형태로 제공되며 -20°C에서 보관합니다.
- 카탈로그번호
- 300-02BC-01M
- 카테고리
- Protein
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Human IFN-beta Recombinant Protein, PeproTech
Applications
| Application | Tested Dilution | Publications |
|---|---|---|
| Western Blot (WB) | - | View 1 publication |
| ELISA | - | View 2 publications |
| Functional Assay | Assay-dependent | View 1 publication |
| Inhibition Assays | - | View 1 publication |
| In vitro Assay | - | View 92 publications |
| Miscellaneous PubMed | - | View 18 publications |
Product Specifications
| 항목 | 내용 |
|---|---|
| Species | Human |
| Published species | Human, Mouse, Pig |
| Expression System | CHO cells |
| Amino acid sequence | MSYNLLGFLQ RSSNFQCQKL LWQLNGRLEY CLKDRMNFDI PEEIKQLQQF QKEDAALTIY EMLQNIFAIF RQDSSSTGWN ETIVENLLAN VYHQINHLKT VLEEKLEKED FTRGKLMSSL HLKRYYGRIL HYLKAKEYSH CAWTIVRVEI LRNFYFINRL TGYLRN |
| Molecular weight | 20 kDa |
| Class | Recombinant |
| Type | Protein |
| Purity | ≥ 95% by SDS-PAGE gel and HPLC analyses |
| Endotoxin concentration | <1 EU/µg |
| Activity | Determined by a cytotoxicity assay using human TF-1 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Purification | Purified |
| Contains | No preservative |
| Storage conditions | -20°C |
Product Specific Information
- Catalog No. 300-02BC-1MG is supplied as 2 × 500 µg (300-02BC-500UG).
- Recombinant Human IFN-beta is a 20.0 kDa protein containing 166 amino acid residues.
- Due to glycosylation, IFN-beta has an approximate MW of 22.3 kDa based on SDS-PAGE and Mass Spectrometry.
- Human IFN-beta (Catalog Number 300-02BC) has replaced Human IFN-beta (Catalog Number 300-02B).
- Shipped at ambient temperature. For storage, handling, and reconstitution information, refer to the lot-specific Certificate of Analysis.
Target Information
Type I Interferons (IFN-alpha/beta) are produced primarily in response to viral infection by natural IFN-producing cells (IPCs) as part of the host immune response. These interferons can also inhibit tumor development. IFN-beta binding activates tyrosine kinases Jak1 and Tyk2, leading to phosphorylation of STAT transcription factors and expression of immune response genes. Members of the toll-like receptor (TLR) family are known to stimulate IFN-beta production. Clinically, IFN-beta is used for the treatment of tumors, infections, and multiple sclerosis.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.